• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Home
  • WATCH NEWS
    • WHAT’S ON FOX
  • ABOUT
    • Meet Our Team
      • Our Journalists
      • Sales & Programming
    • Contact WSFX
      • Sales & Programming
  • Montford Point
  • Welcome Home

Fox Wilmington WSFX-TV

Wilmington, NC | Local news Weather and Sports

  • Local News
    • Unsung Heroes
      • Nominate an Unsung Hero
  • Local Weather
  • National
  • Sports
    • Carolina Panthers
    • Panthers Game Schedule
  • Politics
    • NC Voter Information
  • Health
  • Entertainment
    • What’s on TV?
  • MORE…
    • Technology
    • Science
    • Lifestyle
    • What’s Happening Wilmington

Ivermectin, two other drugs being tested in MUSC COVID-19 clinical trial

September 20, 2021 By WECT

CHARLESTON, S.C. (WCSC) – Ivermectin, a drug used to treat parasitic infections, has been getting a lot of attention recently about whether it should be used to treat COVID-19. Now that drug and two others are being tested as part of a COVID-19 clinical trial that MUSC is participating in.

According to MUSC, there are limited options for COVID-19 treatments that are FDA approved and that are for patients who are not sick enough to be in the hospital. Doctors with MUSC said they hope this trial will help answer some questions about various treatments and dispel any incorrect information that has been swirling.

“We have seen a lot of misinformation out there, and unfortunately, some patients have received non-FDA approved medications outside of a clinical trial,” Rami Zebian, M.D. said in a release. “That is not a safe practice, and we have seen many reports of toxicity – and we have many unanswered questions.”

In addition to Ivermectin, fluticasone—a corticosteroid used for asthma or other conditions—and fluvoxamine—an antidepressant—are also included in the study.

Officials with MUSC said this is a safe way to see if these drugs are actually effective in reducing symptoms of the virus.

According to MUSC, this study is completely remote, so you do not need to live near an MUSC campus to participate. You also can pick which drug you would like to be assigned and you will either be given a placebo or the drug.

MUSC officials said if you are accepted into the trial, you will take the drug as directed, fill out daily surveys and respond to call questionnaires. After 90 days, each participant will receive a $100 Amazon gift card.

In order to be eligible to participate in the study, you have to be at least 30 years old, have a positive covid test in the last 10 days and be experiencing at least two COVID symptoms.

Copyright 2021 WCSC. All rights reserved.

Filed Under: Special Coverage: Coronavirus

Primary Sidebar

 

Follow Us On Facebook



TRENDING NOW

Here’s your chance to give back on #GivingTuesday

Cowboys’ Micah Parsons rips critics for his praise of Eagles ahead of Super Bowl: ‘You people are sick!’

Vanilla Ice says he was shocked by Madonna’s proposal in the early ‘90s: ‘I’m way too young for this’

Nebraska Capitol sees crowds gather for ‘heartbeat’ bill hearings

Arkansas House passes trans bathroom ban for schools

Priscilla Presley speaks out on what would have been Lisa Marie’s 55th birthday

Footer

PUBLIC FILE INFO

Individuals with disabilities who have questions about the content of our public file or website may contact Isabella Gano by phone at
(910) 343-8826 or by email at Isabella.gano@foxwilmington.com

 
 » WSFX FCC Public File
»EEO Report
»Closed Captioning

SITE MAP

  • Local Headlines
  • Coronavirus
  • Local Weather
  • National Headlines
  • Sports
  • Politics
  • Health

WSFX TV

  • Livestream Newscast
  • Meet Our Team
  • Sales & Programming
  • WELCOME HOME
  • Go With The Pros
  • Medically Speaking
  • WHAT’S ON FOX

Copyright © 2023 · American Spirit Media LLC · WSFX TV · Wilmington NC · Terms of Service · Privacy Policy